» Articles » PMID: 37644419

Activities of Daily Living Predict Periprocedural Myocardial Infarction and Injury Following Percutaneous Coronary Intervention: a Cross-sectional Study

Overview
Publisher Biomed Central
Date 2023 Aug 29
PMID 37644419
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In recent years, there has been growing interest in exploring the relationship between activities of daily living (ADL) and cardiovascular diseases. This retrospective cross-sectional study aimed to investigate the association of ADL measured by Barthel index (BI) with periprocedural myocardial infarction (PMI) and injury following percutaneous coronary intervention (PCI).

Methods: Enrolled patients were stratified into impaired and unimpaired ADL groups according to their BI scores. Logistic regressions were conducted to explore the association of ADL on admission with periprocedural myocardial injury and infarction. Restricted cubic spline (RCS) curve and subgroup analysis were also performed.

Results: Totally, 16.4% of patients suffered from PMI; the mean age was 65.8 ± 10.4 years old. RCS analysis showed that the morbidity of periprocedural myocardial infarction and injury showed a downward tendency with increasing BI scores. Multivariable logistic regression analysis demonstrated that impaired ADL was an independent risk factor for periprocedural myocardial infarction (OR = 1.190, 95% CI [1.041, 1.360], P = 0.011) and injury (OR = 1.131, 95% CI [1.017, 1.257], P = 0.023). Subgroup analysis showed that the association between ADL and PMI was founded in several subgroups, while the association between ADL and periprocedural myocardial injury was founded only in BMI ≥ 24 kg/m subgroup.

Conclusion: Impaired ADL at hospital admission was an independent risk factor for periprocedural myocardial infarction and injury among patients following PCI.

References
1.
Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P . Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J. 2018; 39(13):1100-1109. DOI: 10.1093/eurheartj/ehx799. View

2.
Stone G, Maehara A, Muller J, Rizik D, Shunk K, Ben-Yehuda O . Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). JACC Cardiovasc Interv. 2015; 8(7):927-36. DOI: 10.1016/j.jcin.2015.01.032. View

3.
Lindsey J, Kennedy K, Stolker J, Gilchrist I, Mukherjee D, Marso S . Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011; 4(5):474-80. DOI: 10.1161/CIRCINTERVENTIONS.111.962233. View

4.
Bulluck H, Paradies V, Barbato E, Baumbach A, Botker H, Capodanno D . Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous.... Eur Heart J. 2021; 42(27):2630-2642. PMC: 8282317. DOI: 10.1093/eurheartj/ehab271. View

5.
Herrmann J . Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005; 26(23):2493-519. DOI: 10.1093/eurheartj/ehi455. View